The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(2-(Furan-2-yl)-1,2-dihydro-4-oxoquinazolin-3(4H)-yl)-N'-((furan-2-yl)methylene)butanehydrazide ID: ALA4065811
PubChem CID: 137633169
Max Phase: Preclinical
Molecular Formula: C21H20N4O4
Molecular Weight: 392.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CCCN1C(=O)c2ccccc2NC1c1ccco1)N/N=C/c1ccco1
Standard InChI: InChI=1S/C21H20N4O4/c26-19(24-22-14-15-6-4-12-28-15)10-3-11-25-20(18-9-5-13-29-18)23-17-8-2-1-7-16(17)21(25)27/h1-2,4-9,12-14,20,23H,3,10-11H2,(H,24,26)/b22-14+
Standard InChI Key: ARVRBMRIDIWTLJ-HYARGMPZSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
2.4378 -3.3760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4366 -4.1956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1447 -4.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1429 -2.9672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8515 -3.3724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8503 -4.1931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5565 -4.6021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2684 -4.1951 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2696 -3.3744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5589 -2.9608 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5543 -5.4193 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9783 -2.9676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9750 -4.6056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9727 -5.4228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6793 -5.8334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3881 -5.4268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0947 -5.8374 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3904 -4.6096 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0924 -6.6545 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7990 -7.0651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7967 -7.8823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7242 -3.3067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2725 -2.7008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8656 -1.9920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0659 -2.1601 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1379 -8.3628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3882 -9.1407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2055 -9.1430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4600 -8.3665 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
7 11 2 0
9 12 1 0
8 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 1 0
19 20 2 0
20 21 1 0
12 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 12 1 0
21 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 21 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 392.42Molecular Weight (Monoisotopic): 392.1485AlogP: 3.37#Rotatable Bonds: 7Polar Surface Area: 100.08Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.33CX Basic pKa: ┄CX LogP: 2.73CX LogD: 2.73Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.47Np Likeness Score: -1.49
References 1. Khattab SN, Haiba NS, Asal AM, Bekhit AA, Guemei AA, Amer A, El-Faham A.. (2017) Study of antileishmanial activity of 2-aminobenzoyl amino acid hydrazides and their quinazoline derivatives., 27 (4): [PMID:28087274 ] [10.1016/j.bmcl.2017.01.003 ]